Overcoming Barriers for siRNA Therapeutics: From Bench to Bedside
The RNA interference (RNAi) pathway possesses immense potential in silencing any gene in human cells. Small interfering RNA (siRNA) can efficiently trigger RNAi silencing of specific genes. FDA Approval of siRNA therapeutics in recent years garnered a new hope in siRNA therapeutics. However, their t...
Gorde:
Egile Nagusiak: | Muhammad Imran Sajid (Egilea), Muhammad Moazzam (Egilea), Shun Kato (Egilea), Kayley Yeseom Cho (Egilea), Rakesh Kumar Tiwari (Egilea) |
---|---|
Formatua: | Liburua |
Argitaratua: |
MDPI AG,
2020-10-01T00:00:00Z.
|
Gaiak: | |
Sarrera elektronikoa: | Connect to this object online. |
Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|
Antzeko izenburuak
-
Design, Synthesis, and Evaluation of Oleyl-WRH Peptides for siRNA Delivery
nork: Mrigank Shekhar Rai, et al.
Argitaratua: (2024) -
siRNA Therapeutics: From Bench Lab. to Clinics
nork: Cristina Romero-López, et al.
Argitaratua: (2024) -
Cyclic Peptide-Gadolinium Nanocomplexes as siRNA Delivery Tools
nork: Amir Nasrolahi Shirazi, et al.
Argitaratua: (2021) -
Oleyl Conjugated Histidine-Arginine Cell-Penetrating Peptides as Promising Agents for siRNA Delivery
nork: Muhammad Imran Sajid, et al.
Argitaratua: (2022) -
Biotechnological Evolution of siRNA Molecules: From Bench Tool to the Refined Drug
nork: Danielle de Brito e Cunha, et al.
Argitaratua: (2022)